trial · primary record
Ropeginterferon
Polycythemia Vera (PV)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 55 |
| Primary completion | 2029-10 |
| Primary endpoint | Proportion of patients who meet criteria for treatment discontinuation |
| Registry ID | NCT07886801 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:55.622Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07886801
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.